Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apoptosis‐induced T‐cell lymphopenia is related to COVID‐19 severity
Ahmet Çizmecioğlu, Hilal Akay Çizmecioğlu, Mevlüt Hakan Göktepe, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 5, pp. 2867-2874
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 214
PREDICTION OF INTERSTITIAL LUNG DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS PATIENTS: A COHORT STUDY ANALYSIS
D. Khorolskii, ALESYA A. KLIMENKO, Е. С. Першина, et al.
The Bulletin of Contemporary Clinical Medicine (2024) Vol. 17, Iss. 2, pp. 79-84
Open Access | Times Cited: 18
HIV- AND TUBERCULOSIS-ASSOCIATED PERICARDITIS
Е. А. Бородулина, K. Zhilinskaya, DANIIL A. TALAGAEV, et al.
The Bulletin of Contemporary Clinical Medicine (2024) Vol. 17, Iss. 2, pp. 91-97
Open Access | Times Cited: 18
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Lymphopenia as a Predictor for Adverse Clinical Outcomes in Hospitalized Patients with COVID-19: A Single Center Retrospective Study of 4485 Cases
Jianli Niu, Candice Sareli, Daniel Mayer, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 700-700
Open Access | Times Cited: 38
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation
Yulin Dai, Junke Wang, Hyun-Hwan Jeong, et al.
Human Genetics (2021) Vol. 140, Iss. 9, pp. 1313-1328
Open Access | Times Cited: 42
An integrated in-silico Pharmaco-BioInformatics approaches to identify synergistic effects of COVID-19 to HIV patients
Md. Arju Hossain, Md Habibur Rahman, Habiba Sultana, et al.
Computers in Biology and Medicine (2023) Vol. 155, pp. 106656-106656
Open Access | Times Cited: 15
The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells
Thai Hien Tu, Fatima Ezzahra Bennani, Nasser Masroori, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro
Minh Tuyet, Saiaditya Badeti, Chih-Hsiung Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 34
Bioinformatics and system biology approaches to identify pathophysiological impact of COVID-19 to the progression and severity of neurological diseases
Md Habibur Rahman, Humayan Kabir Rana, Silong Peng, et al.
Computers in Biology and Medicine (2021) Vol. 138, pp. 104859-104859
Open Access | Times Cited: 33
Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19
Awatef Ben Jemaa, Noura Salhi, Meriam Ben Othmen, et al.
International Immunopharmacology (2022) Vol. 109, pp. 108781-108781
Open Access | Times Cited: 24
Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation
Enrique Alfaro, Elena Díaz‐García, Sara García-Tovar, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 442-442
Open Access | Times Cited: 20
Serum‐derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID‐19 patients
Tobias Tertel, Sergej Tomić, Jelena Đokić, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 8
Open Access | Times Cited: 20
The Role of High-Density Lipoprotein in COVID-19
Guyi Wang, Jiayi Deng, Jinxiu Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection
Ilias Christodoulou, Ruyan Rahnama, Jonas W. Ravich, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 23
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis
Abraham Degarege, Zaeema Naveed, Josiane Kabayundo, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 563-563
Open Access | Times Cited: 17
Acute kidney injury associated to COVID-19 leads to a strong unbalance of circulant immune mediators
Thalia Medeiros, Gabriel Macedo Costa Guimarães, Fabiana Rabe Carvalho, et al.
Cytokine (2022) Vol. 157, pp. 155974-155974
Open Access | Times Cited: 16
MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity
Monica Gelzo, Alice Castaldo, Antonietta Giannattasio, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Ubiquitination of SARS-CoV-2 ORF7a Prevents Cell Death Induced by Recruiting BclXL To Activate ER Stress
Zhixin Liu, Yanan Fu, Yanping Huang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 15
Hyperinflammatory State and Low T1 Adaptive Immune Response in Severe and Critical Acute COVID-19 Patients
Mercedes García‐Gasalla, María Berman-Riu, Jaime Pons, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Network-based integrative multi-omics approach reveals biosignatures specific to COVID-19 disease phases
Francis E. Agamah, Thomas H. A. Ederveen, Michelle Skelton, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
A glimpse into viral warfare: decoding the intriguing role of highly pathogenic coronavirus proteins in apoptosis regulation
Leyi Cheng, Yajuan Rui, Yanpu Wang, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 2
Investigating the relationship between lymphocyte cells apoptosis and DNA damage and oxidative stress and therapeutic and clinical outcomes of COVID-19 elderly patients
Elaheh Abiri, Mehdi Mirzaii, Majid Moghbeli, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Effective chimeric antigen receptor T cells against SARS-CoV-2
Xueyang Guo, Alexandra Kazanova, Stephanie Thurmond, et al.
iScience (2021) Vol. 24, Iss. 11, pp. 103295-103295
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top